Zilmax is a drug owned by INTERVET, INC. It is protected by 4 US drug patents filed from 2012 to 2030. Out of these, 1 patent is active and 3 patents have expired. Details of Zilmax’s patents and their expiration are given below.
Exclusivity Information
Zilmax holds 1 exclusivity out of which 1 has expired. Details of Zilmax's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 30, 2017 |
About Zilmax
Zilmax is a drug
owned by INTERVET, INC.
Zilmax uses
Zilpaterol Hydrochloride as the active
ingredient.
Active Ingredient:
Zilmax uses
Zilpaterol Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Zilpaterol Hydrochloride ingredient.